- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07484568
Circuit Training With and Without Upper and Lower Limb Resistance Training in Post-CABG Patients
March 16, 2026 updated by: Riphah International University
Effects of Circuit Training With and Without Upper and Lower Limb Resistance Training on Paroxysmal Nocturnal Dyspnea, Functional Capacity and Endurance in Post-CABG Patients
This study aims to evaluate the contrasting effects of circuit training with and without upper and lower limb resistance training on paroxysmal nocturnal dyspnea, functional capacity and endurance on post-CABG patients.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A randomized controlled trial underlined that dynamic strength training dramatically increased peripheral muscular strength and power when combined with endurance training, which may enhance patient prognosis, according to a study done on patients with cardiovascular disease.
According to the study, dynamic strength training is therefore advised as a crucial part of cardiovascular rehabilitation.
The results showed that strength training was associated with lesser increases in intra-arterial blood pressure and cardiac output, indicating sufficient cardiovascular safety.
All things considered, this study questions accepted therapeutic practice and reignites the discussion about the best dynamic strength training.
highlighted the importance of lower limb muscle strengthening in an RCT following CABG surgery; Phase II cardiac rehab showed significant gains in lower limb strength and overall physical and cardiorespiratory performance 6 weeks following hospital discharge, as determined by the Short Physical Performance Battery and 6MWT.
Although, cardiac rehabilitation following coronary artery bypass graft (CABG), has been shown to increase functional capacity and quality of life.
Significant gaps exist in determining the exact exercise prescription for symptom alleviation and functional recovery.
Existing researches primarily focused on conventional continuous aerobic training (CAT) or the circuit-based training alone, with little attention on targeted upper and lower limb resistance training in clinical settings.
Furthermore, the majority of the literature assesses the outcomes such as peak oxygen uptake (V̇O₂max), six-minute walk distance (6-MWD) or general dyspnea scores.
While paroxysmal nocturnal dyspnea is clinically significant and unpleasant condition among post-CABG patients, is understudied.
Dyspnea is usually examined using non-specific tools and techniques during rehabilitation programs but a few studies used cardiac-specific symptom classification tools in post-CABG rehabilitation.
In addition, there is a lack of randomized clinical trials that investigate combined effects of circuit-resistance training in Phase-II cardiac rehabilitation on multiple domains like dyspnea severity, muscle strength, endurance and functional capacity within a single-structured rehabilitation program.
Some studies include small sample sizes or shorter study durations which limit the validity of the findings and the ability to derive clinically significant conclusions.
Furthermore, insufficient information is available from low and middle-income nations where patient characteristics and healthcare resources are differ from those in high-income countries.
This emphasizes the importance of doing context-specific to help define evidence based cardiac rehabilitation procedures.
Therefore, the current study addresses the gaps by systematically comparing the effects of circuit training with and without targeted upper and lower limb resistance training using a complete set of outcome variables.
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Punjab Province
-
Lahore, Punjab Province, Pakistan, 54000
- Punjab Institute of Cardiology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
• Adult CABG surgery candidates aged between 35 and 65 years who underwent uncomplicated CABG surgery within past 3-6 months.
- No history of pre-existing pulmonary disease.
- Clinically stable cardiac status and approval for participation in phase-II cardiac rehabilitation from the cardiac surgeon.
- Patients that presented with the symptoms of mild to moderate levels of paroxysmal nocturnal dyspnea (PND). (38)
- Willingness and availability to participate in the phase-II cardiac rehabilitation program for the study duration.
- Physical ability to perform both upper and lower limb strength training exercise.
- Absence of pre-existing severe orthopedic limitations that could interfere with the exercise performance.
Exclusion Criteria:
- Uncontrolled hypertension, cardiac arrhythmias or any unstable cardiovascular complication that was an absolute contraindication to participate in clinical exercise program.
- Severe pre-existing pulmonary conditions such as COPD or Asthma that could interfere with exercise capacity.
- Severe orthopedic limitations such as arthritis, recent fractures and sternal site infections post-surgery.
- Neurological complications, including stroke, severe neuropathy, balance and coordination abnormalities that could impede physical performance.
- Cognitive impairments that may possibly affect the ability to understand and follow the exercise protocols.
- Participation in some other structured rehabilitation program within the past month.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group A: Circuit Training with upper and lower limb Resistance Training
A series of exercises in a circuit format with Resistance Training: for upper and lower limbs (30-40% of 1-RM)
|
A series of exercises in a circuit format, with 1 minute of exercise followed by 30 seconds of rest.
The circuit was repeated 2-3 times, with a 2-minute break between circuits along with upper and lower limb Resistance exercises (30-40% of 1-RM) using weights and therapeutic bands
|
|
Experimental: Group B: Circuit Training only
Exercises in circuit format (30-40 minutes)
|
A series of exercises in a circuit format, with 1 minute of exercise followed by 30 seconds of rest.
The circuit was repeated 2-3 times, with a 2-minute break between circuits.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Modified Medical Research Council (mMRC)
Time Frame: First day
|
The mMRC Dyspnea Scale is a validated tool to assess the severity of dyspnea among the patients with pulmonary complications.
This scale was utilized to quantify the symptoms of paroxysmal nocturnal dyspnea among the participants in the study, offering an insight to the effectiveness of exercise interventions on the respiratory symptoms
|
First day
|
|
1-Repetition Maximum (1-RM)
Time Frame: First day
|
1-RM is a useful tool in the studies in the studies evaluating the effectiveness of strength training such as those addressing upper and lower limb resistance training.
This test specifies the maximum weight that a subject can lift in a single repetition, providing a precise, quantitative baseline evaluation of dynamic strength.
It can be used as a solid baseline for tracking and comparing strength changes during intervention.
Thus, 1-RM is a practical and objective tool in rehabilitation research.
It allows the researchers to analyze the effectiveness of certain treatments and monitor functional changes over the course of treatment or regimen.
|
First day
|
|
Modified Borg Scale (BORG CR-10):
Time Frame: First day
|
Modified Borg Dyspnea Scale is a highly validated subjective tool, to assess rate of perceived exertion during exercise to monitor exercise intensity and tailor to individual patient in cardiac rehabilitation settings.
It is safe and cost-effective.
It has a rating of 0-10 with zero representing (no breathlessness) and 10 (maximal exertion).
It is a subjective measure of how hard the body is pushing against exertion during exercise.
Specially designed for the assessment of cardiac endurance
|
First day
|
|
6-Minute Walk Test 6-MWT:
Time Frame: First day
|
It is a reliable tool for assessing functional capacity among the patient population that present with underlying cardiovascular and pulmonary conditions.
We used this tool in the assessment of functional capacity among the patients that participated in the study.
This test specifically measures the distance covered in 6 minutes.
In this test the participant walks along a flat straight pathway (usually 30-meter indoor corridors) in six minutes at their own pace.
The maximum distance covered in 6 minutes documented the functional capacity among the participants under study.
|
First day
|
|
Incremental Shuttle Walk Test (ISWT)
Time Frame: First day
|
Incremental Shuttle Walk Test (ISWT) is a highly reliable and valid tool for the assessment of cardiac endurance as a distinct outcome separately from overall functional capacity.
It measures cardiac endurance under progressively increasing workloads within the safe limits.
We used this tool to assess the cardiopulmonary endurance and baseline functional status in CABG population and to measure the improvements post-intervention outcomes.
The test is safe, cost-effective and convenient to implement in all the clinical settings requiring little equipment and simultaneously assesses physiological responses such as heart-rate HR, oxygen saturation SPO2, and blood pressure in accordance with the subjective effort.
|
First day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Qurat ul Ain, MS, Riphah International University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 5, 2025
Primary Completion (Actual)
August 20, 2025
Study Completion (Actual)
December 20, 2025
Study Registration Dates
First Submitted
March 16, 2026
First Submitted That Met QC Criteria
March 16, 2026
First Posted (Actual)
March 20, 2026
Study Record Updates
Last Update Posted (Actual)
March 20, 2026
Last Update Submitted That Met QC Criteria
March 16, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Cardiovascular Diseases
- Heart Diseases
- Respiratory Tract Diseases
- Respiration Disorders
- Signs and Symptoms, Respiratory
- Heart Failure
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Dyspnea
- Dyspnea, Paroxysmal
- Motor Activity
- Movement
- Musculoskeletal Physiological Phenomena
- Musculoskeletal and Neural Physiological Phenomena
- Physical Conditioning, Human
- Exercise
- Circuit-Based Exercise
Other Study ID Numbers
- S24C14G36005 Aaima
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dyspnea, Paroxysmal
-
University of CologneTeva Branded Pharmaceutical Products R&D, Inc.CompletedCancer | Dyspnea, ParoxysmalGermany
-
Centre Hospitalier Annecy GenevoisTerminatedDyspnea, Paroxysmal | Heart Failure, Left SidedFrance
-
Assistance Publique - Hôpitaux de ParisCompletedCongestive Heart Failure | Pulmonary Edema | Dyspnea | ParoxysmalFrance
-
Erasmus Medical CenterUnknownTachycardia, Supraventricular | Tachycardia; Paroxysmal, SupraventricularNetherlands
-
Hospital de Clinicas José de San MartínRecruitingDyspnea During Mechanical VentilationArgentina
-
Longbio PharmaNot yet recruitingParoxysmal Nocturnal HemoglobinuriaChina
-
Regeneron PharmaceuticalsRecruitingParoxysmal Nocturnal HemoglobinuriaSpain, Italy, South Korea, Poland, Brazil, Turkey (Türkiye)
-
Ziekenhuis Oost-LimburgRecruitingDyspnea; CardiacBelgium
-
Novartis PharmaceuticalsRecruitingParoxysmal Nocturnal Hemoglobinuria (PNH)Italy
Clinical Trials on Circuit Training with upper and lower limb Resistance Training
-
Centro Universitario La SalleRecruitingResistance Training | Local Hypoalgesia | Distal Hypoalgesia | Pressure Pain ThresholdsSpain
-
Université de MontréalCanadian Institutes of Health Research (CIHR)Completed
-
Egas Moniz - Cooperativa de Ensino Superior, CRLRecruitingAgeing | Blood Flow RestrictionPortugal
-
Muğla Sıtkı Koçman UniversityCompleted
-
Riphah International UniversityCompleted
-
MTI UniversityCompleted
-
Loewenstein HospitalRecruitingTraining | Robot Assisted TherapyIsrael
-
Donatella MattiaUniversity of Roma La SapienzaCompletedStroke Sequelae | Motor DisordersItaly
-
Jisu KimRecruiting
-
Riphah International UniversityActive, not recruitingStroke | Rehabilitation | Gait BalancePakistan